Medication info

Sama Clopidogrel Tablets (Clopidogrel Sulfate)

Prescription medicationTabletOralExpired
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Sama Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets, 100 tablets (bottle)
Approval status
Expired

MFDS item code 200500781 · Notified 2005.07.26

This product's status changed to Expired on 2024.10.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism associated with atrial fibrillation
Who takes it
Adults
Adult dose
Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment with a loading dose of 300 mg of this drug once daily on the day treatment is started, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. For patients with atrial fibrillation, administer 75 mg of this drug orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. Patients with renal impairment : Treatment experience in patients with renal impairment is limited. Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and bleeding diathesis is limited. This drug may be administered with or without food.

Ingredients

Manufacturer
Sama Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism associated with atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • Non-Q-wave myocardial infarction
  • cardiovascular anomalies
  • myocardial infarction
  • stroke
  • refractory ischemia
  • vascular risk factors
  • stroke
View approved original text

This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, and peripheral arterial disease. It also alleviates cardiovascular symptoms due to acute coronary syndrome and is effective in patients with unstable angina or Non-Q-wave myocardial infarction who have received drug therapy or procedures. Additionally, it helps reduce the risk of stroke and thrombosis in patients with atrial fibrillation who have vascular risk factors, especially when anticoagulation with vitamin K antagonists is not suitable. This treatment plays an important role in managing cardiovascular diseases and benefits in improving the patient's condition.

How to take

Adult dose

Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment with a loading dose of 300 mg of this drug once daily on the day treatment is started, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this drug once daily. 3. For patients with atrial fibrillation, administer 75 mg of this drug orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this drug once daily. Patients with renal impairment : Treatment experience in patients with renal impairment is limited. Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and bleeding diathesis is limited. This drug may be administered with or without food.

Precautions

This medication is an antiplatelet drug that prevents platelets in the blood from sticking together, thereby preventing blood clotting. This drug must be converted into its active form in the liver to be effective; therefore, individuals with impaired function of specific liver enzymes may experience reduced effectiveness. While taking this medication, the risk of bleeding may increase; therefore, it is advisable not to take it if there is any history of bleeding or if the patient is at high risk for bleeding. In particular, patients with gastrointestinal bleeding, intracranial hemorrhage, and bleeding disorders such as hemophilia should not be administered this medication. Patients with severely impaired liver function or women who are breastfeeding should also avoid taking this medication. This medication contains lactose, hence patients with lactose intolerance or related genetic disorders should refrain from taking it. If bleeding symptoms are suspected while taking this medication, consult a physician immediately, and discontinue use 5 to 7 days prior to any scheduled surgery to reduce bleeding risk. Additionally, caution is necessary since taking this medication with other drugs that carry a bleeding risk may further increase the risk of bleeding. Rarely, this medication may cause severe side effects resulting in a rapid decrease in the number of platelets in the blood; therefore, inform healthcare personnel immediately if symptoms of fever or infection occur. During pregnancy, the use of this medication should be limited to essential cases to consider potential effects on the fetus, and it may be discontinued prior to delivery to reduce bleeding risk. In cases of breastfeeding, since this medication may be excreted into breast milk, discuss with a physician whether to continue breastfeeding or discontinue the medication. Elderly patients, or those with impaired kidney or liver function may have an increased risk of bleeding and should use this medication with particular caution. In case of overdose, there may be prolonged bleeding times and the occurrence of bleeding; thus, it is crucial to adhere strictly to the prescribed dosage, as treatment such as platelet transfusion may be necessary in case of overdose. This medication should be stored out of reach of children and it is advisable to avoid transferring it to other containers.

Side effects

Hemorrhage, gastrointestinal bleeding, hemorrhage requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematuria, ocular hemorrhage, intracranial hemorrhage, major hemorrhage, life-threatening hemorrhage, fatal hemorrhage, hemorrhagic stroke, minor hemorrhage, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, urinary tract infection, headache, dizziness, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, depression, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, decreased motor function, tremor, voice disorders, abnormal gait, hyperkinesia, ataxia, sensory disturbances, insomnia, depression, amnesia, anxiety, hyperplasia, abnormal thought, abnormal behavior, arthralgia, myalgia, low back pain, weight loss, weight gain, facial flushing, weakness, rigidity, facial edema, syncope, melena, hemoptysis, muscle hemorrhage, gingival bleeding, anemia, pneumonia, sinusitis, visual disturbances, visual field defects, dry eyes, transient blindness, congestion, tinnitus, taste disturbances, urinary disorders, polyuria, non-protein nitrogen increase, uremia, elevated blood urea nitrogen, hypoglycemia, hyperuricemia, increased liver enzymes, ALT increase, abnormal liver function, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, gynecomastia, elevated prostate-specific antigen, allergic symptoms, ischemic necrosis, gastritis, hemorrhagic gastroenteritis, duodenal ulcer, gastric ulcer, perforated gastric ulcer, upper gastrointestinal tract ulcer bleeding, bloating, hyperbilirubinemia, infectious hepatitis, fatty liver, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, ocular hemorrhage, pulmonary hemorrhage, thrombocytopenia, hypochromic anemia, leukemia, leukopenia, eosinophilia, menorrhagia, hemothorax, herpes zoster, erythematous rash, maculopapular rash, urticaria, renal dysfunction, acute renal failure, fever

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a sealed container to protect it from air and moisture. Additionally, it should be stored at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets, 100 tablets (bottle)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.